(Q38090980)

28 August 2017

Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy (English)

1 reference

28 August 2017

1 reference

neoadjuvant chemotherapy

1 reference

1 reference

Takaki Yoshikawa

1

1 reference

28 August 2017

Yasushi Rino

2

1 reference

28 August 2017

Norio Yukawa

3

1 reference

28 August 2017

Takashi Oshima

4

1 reference

28 August 2017

Akira Tsuburaya

5

1 reference

28 August 2017

Munetaka Masuda

6

1 reference

28 August 2017

19 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

44

1 reference

28 August 2017

1

1 reference

28 August 2017

11-21

1 reference

Estimates of the worldwide mortality from 25 cancers in 1990.

28 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Surgical resection following combination chemotherapy with oral S-1 and biweekly docetaxel in a patient with advanced gastric cancer and a prior coronary artery bypass graft with the right gastroepiploic artery: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Lymph node dissection in the resection of gastric cancer: review of existing evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Guidelines for the management of oesophageal and gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Gastrointestinal cancer: Adjuvant chemotherapy after D2 gastrectomy for gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Disparities in gastric cancer chemotherapy between the East and West

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Tria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0529-1

Extended lymph-node dissection for gastric cancer

21 January 2018

1 reference

12 December 2020

A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomi

1 reference

12 December 2020

Principles of surgical treatment for curable gastric cancer

1 reference

12 December 2020

Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery

1 reference

12 December 2020

Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer

1 reference

12 December 2020

Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case

1 reference

12 December 2020

New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points

1 reference

12 December 2020

A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review

1 reference

12 December 2020

Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Gro

1 reference

12 December 2020

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

1 reference

12 December 2020

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses

1 reference

12 December 2020

Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators

1 reference

12 December 2020

10.1007/S00595-013-0529-1

Identifiers

DOI

1 reference

28 August 2017

1 reference